Home TMU FAQ Sitemap
正體中文
Home Ongoing Clinical Trials
Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202408028 A PHASE 2 PERI-OPERATIVE TRIAL OF FIANLIMAB AND CEMIPLIMAB IN COMBINATION WITH CHEMOTHERAPY VERSUS CEMIPLIMAB IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH RESECTABLE EARLY STAGE (STAGE II TO IIIB [N2]) NSCLC Non snall cell Lung Cancer (NSCLC) SHH Pulmonary Medicine/Sleep Clinic Kang-Yun Lee 02-6620-2589
N202409018 A Phase 3, Randomized, open-label Study of Nivolumab + RelatlimabFixed-dose Combination with Chemotherapy Versus Pembrolizumab with Chemotherapy as First-line Treatment for Participants with Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and with Tumor Cell PD-L1 expression of 1% to 49% Non snall cell Lung Cancer (NSCLC) SHH Pulmonary Medicine/Sleep Clinic Kang-Yun Lee 02-6620-2589
N202409020 A Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy Immunoglobulin A Nephropathy SHH Nephrology YUNG-HO HSU 02-6620-2589
N202409053 A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ - CSU1) Chronic Spontaneous Urticaria SHH Dermatology Woan-Ruoh Lee 02-6620-2589
N202410020 In vitro tumor organoid model for recurrent meningioma and methylation marker study recurrent meningioma SHH Neurosurgery Yu-kai Su 02-6620-2589
N202411001 A Phase III, Randomized, Parallel, Double-blinding, 2-Arm Study to Investigate the Efficacy and Safety of Intra-articular ELIXCYTE (Adipose-Derived Stem Cells) Injection Compared with Placebo in Subjects with Knee Osteoarthritis Knee Osteoarthritis (KOA) SHH Orthopedics CHIH-HWA CHEN 02-6620-2589
1 2 7 8 9 10 11 12 13 14 15 16 / 16

TOP